Preventing invasive salmonellosis in children through vaccination

In situ coating makes it easier for children to swallow and tolerate tablets and capsules

(2015) R El Edelbi et al.   ACTA PAEDIATRICA

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

(2015) Vadrevu Krishna Mohan et al.   CLINICAL INFECTIOUS DISEASES

Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children

(2015) Susanna Esposito et al.   Future Microbiology

Typhoid fever

(2015) John Wain et al.   LANCET

Typhoid fever vaccination strategies

(2015) Kashmira A. Date et al.   VACCINE

A review of typhoid fever transmission dynamic models and economic evaluations of vaccination

(2015) Conall H. Watson et al.   VACCINE

Antimicrobial resistance and management of invasive Salmonella disease

(2015) Samuel Kariuki et al.   VACCINE

Design of Glycoconjugate Vaccines against Invasive African Salmonella enterica Serovar Typhimurium

(2014) S. Rondini et al.   INFECTION AND IMMUNITY

Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children

(2014) Shousun C. Szu et al.   VACCINE

Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh

(2014) Taufiqur R. Bhuiyan et al.   VACCINE

Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid

(2014) Aamir Ali et al.   Human Vaccines & Immunotherapeutics

Estimating the Burden of Paratyphoid A in Asia and Africa

(2014) Michael B. Arndt et al.   PLoS Neglected Tropical Diseases

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

(2014) Vittal Mogasale et al.   Lancet Global Health

Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo

(2013) M.-F. Phoba et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Increasing rates ofSalmonellaParatyphi A and the current status of its vaccine development

(2013) Sushant Sahastrabuddhe et al.   Expert Review of Vaccines

Development of Vi conjugate – a new generation of typhoid vaccine

(2013) Shousun Chen Szu   Expert Review of Vaccines

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2013 and updates on immunization

(2013) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

The challenge of enteric fever

(2013) Claire S. Waddington et al.   JOURNAL OF INFECTION

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

(2013) Zulfiqar A Bhutta et al.   LANCET INFECTIOUS DISEASES

A conjugate vaccine against typhoid fever

(2013) Se Eun Park et al.   LANCET INFECTIOUS DISEASES

Sustained Protection in Mice Immunized with Fractional Doses of Salmonella Enteritidis Core and O Polysaccharide-Flagellin Glycoconjugates

(2013) Raphael Simon et al.   PLoS One

Vaccination for typhoid fever in Sub-Saharan Africa

(2013) Rachel Slayton et al.   Human Vaccines & Immunotherapeutics

Live Oral Typhoid Vaccine Ty21a Induces Cross-Reactive Humoral Immune Responses against Salmonella enterica Serovar Paratyphi A andS. Paratyphi B in Humans

(2012) Rezwanul Wahid et al.   Clinical and Vaccine Immunology

Differing Burden and Epidemiology of Non-Typhi Salmonella Bacteremia in Rural and Urban Kenya, 2006–2009

(2012) Collins Tabu et al.   PLoS One

Incidence and Characteristics of Bacteremia among Children in Rural Ghana

(2012) Maja Verena Nielsen et al.   PLoS One

O:2-CRM197 Conjugates against Salmonella Paratyphi A

(2012) Francesca Micoli et al.   PLoS One

Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination

(2012) Sari H. Pakkanen et al.   VACCINE

Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan

(2012) M. Imran Khan et al.   VACCINE

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

(2011) Vu Dinh Thiem et al.   Clinical and Vaccine Immunology

Invasive nontyphoidal Salmonella disease

(2011) Melita A. Gordon   CURRENT OPINION IN INFECTIOUS DISEASES

Cell-Associated Flagella Enhance the Protection Conferred by Mucosally-Administered Attenuated Salmonella Paratyphi A Vaccines

(2011) Orit Gat et al.   PLoS Neglected Tropical Diseases

Trends and disease burden of enteric fever in Guangxi province, China, 1994–2004

(2010) Bai-Qing Dong et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humans

(2010) Rezwanul Wahid et al.   CLINICAL IMMUNOLOGY

Enteric fever: a travel medicine oriented view

(2010) Eyal Meltzer et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh

(2010) Aliya Naheed et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis

(2010) Elizabeth A Reddy et al.   LANCET INFECTIOUS DISEASES

Polyfunctional T-Cell Responses Are Disrupted by the Ovarian Cancer Ascites Environment and Only Partially Restored by Clinically Relevant Cytokines

(2010) Eric Tran et al.   PLoS One

Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates

(2010) Kenneth L. Roland et al.   VACCINE

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7×1010 colony-forming units

(2010) C.E. Lyon et al.   VACCINE

A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in India

(2009) Dipika Sur et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study

(2009) Atul Kothari et al.   Journal of Infection in Developing Countries

A Patient With Paratyphoid A Fever: An Emerging Problem in Asia and Not Always a Benign Disease

(2008) Anil Pandit et al.   JOURNAL OF TRAVEL MEDICINE

The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries

(2008) Joseph Cook et al.   VACCINE

Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993–2003

(2007) Ashish P. Maskey et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE